title: Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder.
abstract: OBJECTIVE
  Clinical data indicate that drug resistance to chemotherapy may occur in all stages of transitional cell cancer (TCC). Glutathione S-transferases (GSTs) are a family of detoxification enzymes composed of four different classes, denoted alpha (GSTA), mu (GSTM), pi (GSTP), and theta (GSTT), each containing one or more homo- or heterodimeric isoforms (GSTA1-1, GSTA1-2, and so forth), GSTs play a prominent role in drug detoxification and have been associated with resistance of tumor cells to anticancer agents. GST activity and isoenzyme levels were studied in TCC and normal bladder mucosa.
  
  
  METHODS
  Enzyme activity was studied in samples of TCC (n = 37), adjacent normal bladder mucosa (n = 37), and in bladder mucosa of control patients without TCC (n = 46). GST isoenzyme composition was studied in mucosa and TCC of 14 patients and 11 controls.
  
  
  RESULTS
  The mucosa of patients with TCC showed GST activity (191 +/- 21 nmol/min/mg cytosolic protein), similar to the mucosa of controls (176 +/- 15 nmol/min/mg). GST activity was significantly increased in TCC (666 +/- 157 nmol/min/mg) in comparison with adjacent mucosa (P < 0.003). In mucosa samples, the levels of GSTA (A1-1, A1-2, and A2-2) were below the detection limit in 92% of the samples. GSTM (GSTM1-1) was found in 9 controls and in 7 patients with TCC but not in the other 7 patients, whereas GSTP (GSTP1-1) could be detected in all samples. The levels of GSTM1-1 and GSTP1-1 were similar in mucosa of patients and controls. The mean relative increase of GSTP1-1 levels in TCC was 4.6-fold (P < 0.002). In the 7 patients with GSTM1-1-detectable expression in adjacent normal mucosa, mean GSTM1-1 levels in TCC were increased 2.8-fold compared with mean levels in normal adjacent mucosa (P < 0.02). GSTA was measured in five samples of TCC at relatively low levels.
  
  
  CONCLUSIONS
  Overexpression of GSTP1-1 and GSTM1-1 may suggest that in the process of TCC carcinogenesis, a selection pressure occurs, resulting in a tumor with enhanced detoxification properties, including that of therapeutic drugs.
authors.affiliation: Department of Urology, Free University Hospital, Amsterdam, The Netherlands.
authors.forename: C L
authors.initials: CL
authors.lastname: Berendsen
authors.forename: W H
authors.initials: WH
authors.lastname: Peters
authors.forename: P G
authors.initials: PG
authors.lastname: Scheffer
authors.forename: A A
authors.initials: AA
authors.lastname: Bouman
authors.forename: E
authors.initials: E
authors.lastname: Boven
authors.forename: D W
authors.initials: DW
authors.lastname: Newling
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002295:Carcinoma, Transitional Cell / Q000737:chemistry / Q000201:enzymology*; D005260:Female; D005982:Glutathione Transferase / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes / Q000032:analysis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000737:chemistry / Q000378:metabolism; D001743:Urinary Bladder / Q000737:chemistry / Q000378:metabolism; D001749:Urinary Bladder Neoplasms / Q000737:chemistry / Q000201:enzymology*
chemical_list: D007527:Isoenzymes; D005982:Glutathione Transferase